📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer. (2018)

First Author: Lane JA

Attributed to: Mendelian randomization to hypothesis-free causal inference funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1940-6207.capr-18-0147

PubMed Identifier: 30309839

Publication URI: http://europepmc.org/abstract/MED/30309839

Type: Journal Article/Review

Volume: 11

Parent Publication: Cancer prevention research (Philadelphia, Pa.)

Issue: 11

ISSN: 1940-6215